Scientific article

Traitement de la sclérose en plaques : nouveautés et complications

Published inRevue médicale suisse, vol. 9, no. 384, p. 940-943
Publication date2013

A new therapeutic era opened for multiple sclerosis (MS) with the appearance of molecules given p.o. and/or molecules with greater efficiency. Early diagnosis is critical, as the time and the choice of therapeutic intervention. The initiation of treatments must be personalized, including the risks associated with MS and those potentially related to the treatment chosen, answering the question . Monitoring tools that allow to objectively evaluate: I) MS activity and aggressiveness for each patient and 2) the safety of treatments and their risks of complications, must be further investigated.

  • Drug-Related Side Effects and Adverse Reactions
  • Humans
  • Multiple Sclerosis/drug therapy
Citation (ISO format)
SCHLUEP, Myriam, LALIVE D’EPINAY, Patrice, DU PASQUIER, Renaud Alfred Robert. Traitement de la sclérose en plaques : nouveautés et complications. In: Revue médicale suisse, 2013, vol. 9, n° 384, p. 940–943.
Main files (1)
Article (Published version)
ISSN of the journal1660-9379

Technical informations

Creation11/30/2016 3:21:00 PM
First validation11/30/2016 3:21:00 PM
Update time03/15/2023 1:05:46 AM
Status update03/15/2023 1:05:46 AM
Last indexation01/16/2024 10:36:08 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack